High Endothelial Venules As Potential Gateways for Therapeutics
Overview
Authors
Affiliations
High endothelial venules (HEVs) are specialized blood vessels that support the migration of lymphocytes from the bloodstream into lymph nodes (LNs). They are also formed ectopically in mammalian organs affected by chronic inflammation and cancer. The recent arrival of immunotherapy at the forefront of many cancer treatment regimens could boost a crucial role for HEVs as gateways for the treatment of cancer. In this review, we describe the microanatomical and biochemical characteristics of HEVs, mechanisms of formation of newly made HEVs, immunotherapies potentially dependent on HEV-mediated T cell homing to tumors, and finally, how HEV-targeted therapies might be used as a complementary approach to potentially shape the therapeutic landscape for the treatment of cancer and immune-mediated diseases.
Hou S, Zhang J, Zhang Z, Qu H, Li S, Jiang Y Clin Transl Med. 2025; 15(2):e70216.
PMID: 39968688 PMC: 11836620. DOI: 10.1002/ctm2.70216.
Xu Q, Shao D Front Immunol. 2024; 15:1487610.
PMID: 39691707 PMC: 11649667. DOI: 10.3389/fimmu.2024.1487610.
Akter R, Masum M, Biswas S, Rubel M, Sarkar S, Islam M Heliyon. 2024; 10(20):e39621.
PMID: 39497952 PMC: 11532882. DOI: 10.1016/j.heliyon.2024.e39621.
Tertiary Lymphoid Structures in Microorganism-Related Cancer.
Deng S, Yang X, He L, Hou Y, Meng H Cancers (Basel). 2024; 16(20).
PMID: 39456558 PMC: 11505735. DOI: 10.3390/cancers16203464.
Lymphatic system regulation of anti-cancer immunity and metastasis.
Lei P, Fraser C, Jones D, Ubellacker J, Padera T Front Immunol. 2024; 15:1449291.
PMID: 39211044 PMC: 11357954. DOI: 10.3389/fimmu.2024.1449291.